Best Partial Nephrectomy with Robotic Assist Doctors in Tampa, FL

A native of Connecticut, Dr Poch entered Brown University as an undergraduate in the Program of Liberal Medical Education. He graduated with a BA in Biology from Brown University and went on to complete medical school at Brown Medical School. He stayed in Providence, Rhode Island at Brown University to complete his urology residency training.After residency he moved to Buffalo, New York to complete a Society for Urologic Oncology accredited urologic oncology fellowship at Roswell Park Cancer Institute. His clinical interests include bladder, kidney and prostate cancer with an emphasis on minimally invasive surgery and robotics.

Dr Yu received her MD from McGill University in Montreal, Quebec, Canada. She completed a Urology Residency at the McGill University Health Center. Subsequently, she spent two years in Boston, Massachusetts where she completed a Urologic Oncology Fellowship in the Combined Harvard Program at Massachusetts General Hospital and Brigham and Women's Hospital. Dr Yu's clinical practice focuses on the surgical treatment of urologic cancers including prostate, bladder, kidney, penile and testicular cancer, using minimally invasive (laparoscopic and robotic) and open techniques. She is interested in surgical outcomes research and quality improvement with a focus on bladder and prostate cancers.

Dr Roger Li is a genitourinary oncologist whose clinical practice focuses on the surgical treatment of bladder, prostate, kidney and penile cancers. He offers a variety of treatment options, including open, laparoscopic, and robotic-assisted procedures, as well as nerve sparing approaches based on the clinical scenario. Prior to joining Moffitt, Dr Li completed advanced urologic oncology training at the MD Anderson Cancer Center in Houston, Texas. Dr Li's research interest includes the genomic characterization of genitourinary malignancies in attempt to tailor therapy specific to the patient, as well as the development of novel immunotherapeutic strategies in treating early stage bladder cancer.

Dr Manley earned his MD degree at Temple University, Philadelphia, Pennsylvania. He completed a Urologic Residency at Washington University, St. Louis, Missouri anda Urologic Oncology Fellowship at Memorial Sloan Kettering Cancer Center in New York. Dr Manley's clinical practice centers on malignant tumors of the prostate, kidneys, bladder and testis. Using a variety of surgical techniques, including robotic and open surgery, he supports the comprehensive treatment plans for patients with genitourinary cancers at Moffitt.

A native of Connecticut, Dr Poch entered Brown University as an undergraduate in the Program of Liberal Medical Education. He graduated with a BA in Biology from Brown University and went on to complete medical school at Brown Medical School. He stayed in Providence, Rhode Island at Brown University to complete his urology residency training.After residency he moved to Buffalo, New York to complete a Society for Urologic Oncology accredited urologic oncology fellowship at Roswell Park Cancer Institute. His clinical interests include bladder, kidney and prostate cancer with an emphasis on minimally invasive surgery and robotics.

Dr Yu received her MD from McGill University in Montreal, Quebec, Canada. She completed a Urology Residency at the McGill University Health Center. Subsequently, she spent two years in Boston, Massachusetts where she completed a Urologic Oncology Fellowship in the Combined Harvard Program at Massachusetts General Hospital and Brigham and Women's Hospital. Dr Yu's clinical practice focuses on the surgical treatment of urologic cancers including prostate, bladder, kidney, penile and testicular cancer, using minimally invasive (laparoscopic and robotic) and open techniques. She is interested in surgical outcomes research and quality improvement with a focus on bladder and prostate cancers.

Dr Roger Li is a genitourinary oncologist whose clinical practice focuses on the surgical treatment of bladder, prostate, kidney and penile cancers. He offers a variety of treatment options, including open, laparoscopic, and robotic-assisted procedures, as well as nerve sparing approaches based on the clinical scenario. Prior to joining Moffitt, Dr Li completed advanced urologic oncology training at the MD Anderson Cancer Center in Houston, Texas. Dr Li's research interest includes the genomic characterization of genitourinary malignancies in attempt to tailor therapy specific to the patient, as well as the development of novel immunotherapeutic strategies in treating early stage bladder cancer.

Dr Manley earned his MD degree at Temple University, Philadelphia, Pennsylvania. He completed a Urologic Residency at Washington University, St. Louis, Missouri anda Urologic Oncology Fellowship at Memorial Sloan Kettering Cancer Center in New York. Dr Manley's clinical practice centers on malignant tumors of the prostate, kidneys, bladder and testis. Using a variety of surgical techniques, including robotic and open surgery, he supports the comprehensive treatment plans for patients with genitourinary cancers at Moffitt.